Caroline  Apovian, MD, FACP, FACN's portrait

Caroline Apovian, MD, FACP, FACN

Professor of Medicine and Pediatrics
Section of Endocrinology, Diabetes, and Nutrition
Boston University School of Medicine
Boston, MA
Dr. Apovian is a member of the OnTrack Diabetes Editorial Board.

About Caroline Apovian, MD, FACP, FACN

Caroline Apovian is Professor of Medicine and Pediatrics, in the Section of Endocrinology, Diabetes, and Nutrition at Boston University School of Medicine, USA. She is also Director of the Center for Nutrition and Weight Management at Boston Medical Center, USA. Dr. Apovian is a nationally and internationally recognized authority on nutrition and has been in the field of obesity and nutrition since 1990. Her current research interests are in: weight loss and its effects on endothelial cell function, adipose cell metabolism and inflammation, research in the bariatric surgery population, and novel pharmacotherapeutic antiobesity agents. She is also an expert in the technique for subcutaneous adipose tissue biopsies, and has been performing these biopsies on research subjects for over 10 years. She was on the expert panel for updating the 2013 AHA/ACC/TOS Clinical Guidelines for the Management of Overweight and Obesity in Adults.

Dr. Apovian was a recipient of the Physician Nutrition Specialist Award given by the American Society of Clinical Nutrition. This was for her work on developing and providing nutrition education, to medical students and physicians in training at Boston University School of Medicine. She has published over 200 articles, chapters, and reviews on the topics of: obesity, nutrition, and the relationship between adipose tissue and risk of developing cardiovascular disease. Dr. Apovian has recently published a new book entitled the “The Age-Defying Diet” and has also written the popular books for “The Overnight Diet” and “The ALLI Diet Plan”.

Dr. Apovian has been a member of The Obesity Society since 1992, and has served on the Clinical Committee as well as Secretary/Treasurer and the Executive Committee from 2005 to 2008.  She has been a faculty speaker and has presented papers at several of the Society's Annual Scientific Meeting and until recently she served as Associate Editor for the Society's journal, Obesity.


Articles Reviewed by Caroline Apovian, MD, FACP, FACN

Lorcaserin: Can This New Weight Loss Drug Delay or Reverse Diabetes?

A prescription weight loss drug, lorcaserin (Belviq), helps not only with weight loss but also in reversing diabetes or delaying its onset, according to new research involving 12,000 people.
Lorcaserin, a prescription weight-loss drug, helps with weight loss but also in reversing or delaying the onset of diabetes, according to new research involving 12,000 people.

Financial Disclosures for Caroline Apovian, MD, FACP, FACN

OnTrack Diabetes, a Remedy Health Media, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.

To help achieve this goal, OnTrack Diabetes requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.

The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.

Author's Statement

I, the undersigned, declare that neither I nor members of my immediate family have a financial interests or affiliation with commercial companies whose products and / or services may be mentioned in the materials I have authored, edited or reviewed for presentation on Remedy Health Media, LLC’s websites.
There are no disclosures for this author